Literature DB >> 33414391

Efficacy of telemedicine for persons with type 1 diabetes during Covid19 lockdown.

Federico Boscari1, Sara Ferretto1, Ambra Uliana1, Angelo Avogaro1, Daniela Bruttomesso2.   

Abstract

BACKGROUND: Starting March 2020 the Italian Government imposed a lockdown to limit the spread of SARS-CoV-2. During lockdown outpatient visits were limited and telemedicine (TM) was encouraged.
METHODS: We retrospectively analyzed data from continuous or flash glucose monitoring systems shared through different cloud systems during the lockdown by subjects with type 1 diabetes and compared data obtained 4 weeks before and 4 weeks after structured telephonic visit. Variables considered were mean glucose, time spent in target (70-180 mg/dl), hypoglycemia (<70 mg/dl) and hyperglycemia (>180 mg/dl), coefficient of variation, and length of sensor use.
RESULTS: During the 4 weeks following the telephonic visit there was an improvement of glycemic control, with a significant reduction of mean glucose values (161.1 before vs 156.3 mg/dl after, p = 0.001), an increase of the time spent in target (63.6 vs 66.3, p = 0.0009) and a reduction of time spent in hyperglycemia (33.4 vs 30.5, p = 0.002). No changes were observed regarding glucose variability, time spent in hypoglycemia, and length of sensor use. Similar results were observed in subjects treated with multiple daily injections or continuous subcutaneous insulin infusion.
CONCLUSIONS: A structured telephonic visit appears to be an effective way to replace or integrate routine visits in particular conditions.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33414391      PMCID: PMC7790327          DOI: 10.1038/s41387-020-00147-8

Source DB:  PubMed          Journal:  Nutr Diabetes        ISSN: 2044-4052            Impact factor:   5.097


  17 in total

1.  Telemedicine for Diabetes After the COVID-19 Pandemic: We Can't Put the Toothpaste Back in the Tube or Turn Back the Clock.

Authors:  David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2020-06-06

2.  The Silver Lining to COVID-19: Avoiding Diabetic Ketoacidosis Admissions with Telehealth.

Authors:  Anne L Peters; Satish K Garg
Journal:  Diabetes Technol Ther       Date:  2020-05-05       Impact factor: 6.118

3.  Home Telemedicine (CoYoT1 Clinic): A Novel Approach to Improve Psychosocial Outcomes in Young Adults With Diabetes.

Authors:  Marwan Bakhach; Mark W Reid; Elizabeth A Pyatak; Cari Berget; Cindy Cain; John Fred Thomas; Georgeanna J Klingensmith; Jennifer K Raymond
Journal:  Diabetes Educ       Date:  2019-06-27       Impact factor: 2.140

4.  Inpatient Transition to Virtual Care During COVID-19 Pandemic.

Authors:  Morgan S Jones; April L Goley; Bonnie E Alexander; Scott B Keller; Marie M Caldwell; John B Buse
Journal:  Diabetes Technol Ther       Date:  2020-05-12       Impact factor: 6.118

5.  Managing New-Onset Type 1 Diabetes During the COVID-19 Pandemic: Challenges and Opportunities.

Authors:  Satish K Garg; David Rodbard; Irl B Hirsch; Gregory P Forlenza
Journal:  Diabetes Technol Ther       Date:  2020-04-17       Impact factor: 6.118

Review 6.  Continuous Glucose Monitoring Sensors: Past, Present and Future Algorithmic Challenges.

Authors:  Andrea Facchinetti
Journal:  Sensors (Basel)       Date:  2016-12-09       Impact factor: 3.576

7.  Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy.

Authors:  Benedetta Maria Bonora; Federico Boscari; Angelo Avogaro; Daniela Bruttomesso; Gian Paolo Fadini
Journal:  Diabetes Ther       Date:  2020-05-11       Impact factor: 2.945

8.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

9.  COVID-19 in Italy: momentous decisions and many uncertainties.

Authors:  Marzia Lazzerini; Giovanni Putoto
Journal:  Lancet Glob Health       Date:  2020-03-18       Impact factor: 26.763

Review 10.  Coronavirus disease 2019: What we know?

Authors:  Feng He; Yu Deng; Weina Li
Journal:  J Med Virol       Date:  2020-03-28       Impact factor: 20.693

View more
  8 in total

1.  Improved CGM Glucometrics and More Visits for Pediatric Type 1 Diabetes Using Telemedicine During 1 Year of COVID-19.

Authors:  Tara Kaushal; Liane J Tinsley; Lisa K Volkening; Christine Turcotte; Lori M Laffel
Journal:  J Clin Endocrinol Metab       Date:  2022-09-28       Impact factor: 6.134

Review 2.  Telemedicine for the Clinical Management of Diabetes; Implications and Considerations After COVID-19 Experience.

Authors:  Saula Vigili de Kreutzenberg
Journal:  High Blood Press Cardiovasc Prev       Date:  2022-05-17

Review 3.  Current treatment options and challenges in patients with Type 1 diabetes: Pharmacological, technical advances and future perspectives.

Authors:  Federico Boscari; Angelo Avogaro
Journal:  Rev Endocr Metab Disord       Date:  2021-03-23       Impact factor: 6.514

4.  Building and implementing a contactless clinical trial protocol for patients with COVID-19: A Korean perspective.

Authors:  Ye Seul Bae; Sumi Sung; Jungeun Lee; Hyeonji Lee; Eui Kyu Chie
Journal:  Front Med (Lausanne)       Date:  2022-09-15

5.  COVID-19 and diabetes mellitus. Importance of glycemic control.

Authors:  Núria Alonso; Sol Batule
Journal:  Clin Investig Arterioscler       Date:  2021 May-Jun

Review 6.  Telemonitoring, Telemedicine and Time in Range During the Pandemic: Paradigm Change for Diabetes Risk Management in the Post-COVID Future.

Authors:  Thomas Danne; Catarina Limbert; Manel Puig Domingo; Stefano Del Prato; Eric Renard; Pratik Choudhary; Alexander Seibold
Journal:  Diabetes Ther       Date:  2021-08-02       Impact factor: 2.945

Review 7.  Glycaemic control during the lockdown for COVID-19 in adults with type 1 diabetes: A meta-analysis of observational studies.

Authors:  Monia Garofolo; Michele Aragona; Cosimo Rodia; Pierpaolo Falcetta; Alessandra Bertolotto; Fabrizio Campi; Stefano Del Prato; Giuseppe Penno
Journal:  Diabetes Res Clin Pract       Date:  2021-09-23       Impact factor: 5.602

8.  Glucose control in diabetes during home confinement for the first pandemic wave of COVID-19: a meta-analysis of observational studies.

Authors:  Giovanni Antonio Silverii; Chiara Delli Poggi; Ilaria Dicembrini; Matteo Monami; Edoardo Mannucci
Journal:  Acta Diabetol       Date:  2021-06-22       Impact factor: 4.280

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.